EndoVia
1 known investors
Find your way into EndoVia
142 people in our graph share verified history with the EndoVia team — schools, employers, funds. One of them is your warm intro.
Henry Brodieunlockedknows Jan Rožanc · together at Oxford Brookes University (overlapped)
×10knows the team · via Oxford Brookes University
knows the team · via University of Luxembourg
EndoVia develops a precision oncology platform that combines experimental biology with computational modeling to match cannabinoid-based cancer treatments to individual patients. It maps cannabinoid and extract libraries against biological targets, uses subtype-specific tumor models and multi-omics profiling, and builds predictive network and digital-twin models to guide therapeutic development.
Founders & leadership
JR
Jan RožancinCo-Founder & CEOJan Rožanc has training in systems biology and pharmacology, with expertise in cannabinoids and the endocannabinoid system spanning molecular mechanism studies, signaling networks, and computational approaches. He founded EndoVia Therapeutics to develop a precision oncology platform that uses experimental biology, systems pharmacology, and computational modeling to predict responses to cannabinoid-based cancer treatments and inform patient stratification.
Investors · 1
Frequently asked questions
- What does EndoVia do?
- EndoVia develops a precision oncology platform that combines experimental biology with computational modeling to match cannabinoid-based cancer treatments to individual patients. It maps cannabinoid and extract libraries against biological targets, uses subtype-specific tumor models and multi-omics profiling, and builds predictive network and digital-twin models to guide therapeutic development.
- Who founded EndoVia?
- EndoVia was founded by Jan Rožanc.
- Who are EndoVia's investors?
- EndoVia's investors include Vesna Advisors.